These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6457049)

  • 41. A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity.
    Smirnov MD; Safa O; Regan L; Mather T; Stearns-Kurosawa DJ; Kurosawa S; Rezaie AR; Esmon NL; Esmon CT
    J Biol Chem; 1998 Apr; 273(15):9031-40. PubMed ID: 9535891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function.
    Liaw PC; Neuenschwander PF; Smirnov MD; Esmon CT
    J Biol Chem; 2000 Feb; 275(8):5447-52. PubMed ID: 10681521
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C.
    Rosing J; Hoekema L; Nicolaes GA; Thomassen MC; Hemker HC; Varadi K; Schwarz HP; Tans G
    J Biol Chem; 1995 Nov; 270(46):27852-8. PubMed ID: 7499257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Membrane binding properties of blood coagulation Factor V and derived peptides.
    Pusey ML; Nelsestuen GL
    Biochemistry; 1984 Dec; 23(25):6202-10. PubMed ID: 6441598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of prothrombinase complex by plasma proteinase inhibitors.
    Ellis V; Scully MF; Kakkar VV
    Biochemistry; 1984 Nov; 23(24):5882-7. PubMed ID: 6335402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals.
    Camire RM; Kalafatis M; Cushman M; Tracy RP; Mann KG; Tracy PB
    J Biol Chem; 1995 Sep; 270(35):20794-800. PubMed ID: 7657663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protein C.
    Esmon CT
    Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Electron microscopy and hydrodynamic properties of blood clotting factor V and activation fragments of factor V with phospholipid vesicles.
    Lampe PD; Pusey ML; Wei GJ; Nelsestuen GL
    J Biol Chem; 1984 Aug; 259(15):9959-64. PubMed ID: 6746672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The contribution of bovine Factor V and Factor Va to the activity of prothrombinase.
    Nesheim ME; Taswell JB; Mann KG
    J Biol Chem; 1979 Nov; 254(21):10952-62. PubMed ID: 500617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Importance of protein S and phospholipid for activated protein C-mediated cleavages in factor Va.
    Norstrøm EA; Steen M; Tran S; Dahlbäck B
    J Biol Chem; 2003 Jul; 278(27):24904-11. PubMed ID: 12707283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A domain of membrane-bound blood coagulation factor Va is located far from the phospholipid surface. A fluorescence energy transfer measurement.
    Isaacs BS; Husten EJ; Esmon CT; Johnson AE
    Biochemistry; 1986 Aug; 25(17):4958-69. PubMed ID: 3768326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of a protein with membrane vesicles at the collisional limit: studies with blood coagulation factor Va light chain also suggest major differences between small and large unilamellar vesicles.
    Abbott AJ; Nelsestuen GL
    Biochemistry; 1987 Dec; 26(24):7994-8003. PubMed ID: 3427119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anionic phospholipids lose their procoagulant properties when incorporated into high density lipoproteins.
    Oslakovic C; Krisinger MJ; Andersson A; Jauhiainen M; Ehnholm C; Dahlbäck B
    J Biol Chem; 2009 Feb; 284(9):5896-904. PubMed ID: 19129179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coagulation factor Va binds to human umbilical vein endothelial cells and accelerates protein C activation.
    Maruyama I; Salem HH; Majerus PW
    J Clin Invest; 1984 Jul; 74(1):224-30. PubMed ID: 6547457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protein S and the regulation of activated protein C.
    Walker FJ
    Semin Thromb Hemost; 1984 Apr; 10(2):131-8. PubMed ID: 6234659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C.
    Somajo S; Koshiar RL; Norström E; Dahlbäck B
    Thromb Res; 2014 Jul; 134(1):144-52. PubMed ID: 24835672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
    Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
    Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of activated protein C by platelets.
    Jane SM; Mitchell CA; Hau L; Salem HH
    J Clin Invest; 1989 Jan; 83(1):222-6. PubMed ID: 2910909
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synergistic cofactor function of factor V and protein S to activated protein C in the inactivation of the factor VIIIa - factor IXa complex -- species specific interactions of components of the protein C anticoagulant system.
    Shen L; He X; Dahlbäck B
    Thromb Haemost; 1997 Sep; 78(3):1030-6. PubMed ID: 9308749
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of annexin V on the activity of the anticoagulant proteins C and S.
    Sun J; Bird P; Salem HH
    Thromb Res; 1993 Feb; 69(3):279-87. PubMed ID: 8475478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.